Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

EU Clears BioNTech-Pfizer’s Adapted Comirnaty XBB.1.5 COVID-19 Vaccine for Fall Campaigns

(IN BRIEF) The European Union Commission has given the green light for the use of the adapted Comirnaty XBB.1.5 COVID-19 vaccine, developed by BioNTech-Pfizer, in Member States’ upcoming fall vaccination campaigns. This marks the third adaptation of the Comirnaty vaccine … Read the full press release

Internet-Delivered Cognitive Behavioral Therapy Offers Cost-Effective Alternative for Depression and Anxiety Treatment, Study Finds

(IN BRIEF) A study conducted by the University of York, in collaboration with ieso Digital Health Ltd and Dorset HealthCare University NHS Trust, has found that internet-delivered cognitive behavioral therapy (CBT) offers greater cost-effectiveness and comparable clinical effectiveness compared to … Read the full press release

Birthweight Relative to Gestational Age Influences Child Cognitive Development, Study Reveals

(IN BRIEF) A recent study by Bielefeld University and the University of Warwick investigated the connection between infant birthweight, gestational age, and subsequent cognitive issues. The study, published in JAMA Network Open, suggests that a larger birthweight is generally linked … Read the full press release

Early Teenage Smoking in Boys Linked to Health Risks in Future Children, Reveals University of Southampton Study

(IN BRIEF) A recent study conducted by researchers from the University of Southampton and the University of Bergen reveals that boys who smoke during their early teenage years are at risk of damaging the genes of their future children. The … Read the full press release

University of Leeds Spin-Out Mimetrik Secures £2M Investment for AI-Driven Dentistry Innovations

(IN BRIEF) A spin-out company called Mimetrik from the University of Leeds has secured a £2 million seed funding round led by Northern Gritstone to accelerate the development of AI-driven dentistry products. Mimetrik, established in 2020 within the University’s Nexus … Read the full press release

EMA Recommends Pfizer and BioNTech’s Omicron XBB.1.5-Adapted COVID-19 Vaccine for Approval

(IN BRIEF) Pfizer and BioNTech have received a recommendation for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The recommendation includes the administration of a single … Read the full press release

EMA Backs Comirnaty Omicron XBB.1.5 Vaccine for Varied Ages Amid Variant Concerns

(IN BRIEF) EMA proposes Comirnaty Omicron XBB.1.5 vaccine for ages 6 months+, tailored to combat Omicron XBB.1.5 variant. One dose suffices for ages 5+, while kids 6 months to 4 years may need 1 or 3 doses based on prior … Read the full press release

Fondation Botnar Invests CHF 50 Million to Expand Child Health Research at ETH Zurich and University of Basel

(IN BRIEF) Fondation Botnar is contributing an additional CHF 50 million to the University of Basel and ETH Zurich to expand the Botnar Research Centre for Child Health (BRCCH). This funding will facilitate the establishment of six new professorships focusing … Read the full press release

Global Campaign ‘The Meningitis Flag’ Launched to Raise Meningitis Awareness Ahead of Paris 2024 Paralympic Games

(IN BRIEF) Meningitis Research Foundation, the Confederation of Meningitis Organisations (CoMO), and Sanofi have united to introduce ‘The Meningitis Flag,’ a worldwide campaign aimed at increasing awareness in the fight against meningitis. The campaign, supported by para-athletes including Ellie Challis, … Read the full press release

Carmeuse Supports Abbey Rose Foundation 5K Trail Run/Walk to Prevent Sudden Infant Death Syndrome

(IN BRIEF) Carmeuse Huron Operation continued its tradition of supporting regional 5K races by participating in the Abbey Rose Foundation 5K Trail Run/Walk & Kids Fun Run. The event, held at Fabens Park in Huron, Ohio, saw participants navigating diverse … Read the full press release

Sandoz Expands Hospital Offering and Anti-Infectives Portfolio with Mycamine® Brand Rights Acquisition

(IN BRIEF) Sandoz, a global leader in generic and biosimilar medicines, has successfully acquired the worldwide brand rights for the systemic antifungal agent Mycamine® (micafungin sodium) from Astellas. This acquisition bolsters Sandoz’s position in the global hospital sector and enhances … Read the full press release

Swiss Re Introduces AI-Powered Mental Health App, Collaborates with Wysa for Holistic Support

(IN BRIEF) Swiss Re Reinsurance Solutions has partnered with Wysa to launch Wysa Assure, an AI-driven mental health support app. Combining Swiss Re’s risk expertise with Wysa’s AI technology, the app offers on-demand mental health assistance through an AI chatbot … Read the full press release

TechMed Researcher Annemieke Witteveen Nominated as Finalist for New Scientist Science Talent 2023

(IN BRIEF) Assistant Professor Annemieke Witteveen, from the Biomedical Signals and Systems department at the Faculty of EEMCS (TechMed Centre), has been nominated for the prestigious New Scientist Science Talent Prize. This award highlights emerging researchers, with Witteveen and 14 … Read the full press release

Swiss TPH, BASF, and Promega Collaborate on Novel Insect Control Methods to Combat Malaria and Mosquito-Borne Diseases

(IN BRIEF) The Swiss Tropical and Public Health Institute (Swiss TPH), in collaboration with BASF and Promega, is partnering to research and develop innovative insect control tools for combating mosquito-borne diseases like malaria. The project, funded by the Bill & … Read the full press release

Boehringer Ingelheim Advances Dual Agonist Survodutide to Phase III Trials, Demonstrating Significant Weight Loss in Phase II Study

(IN BRIEF) Pharmaceutical company Boehringer Ingelheim has declared its intention to move forward with survodutide, a dual agonist targeting the glucagon/GLP-1 receptors, into three Phase III clinical trials for individuals suffering from overweight or obesity. This decision stems from promising … Read the full press release

Lindner Clean Rooms Secures Follow-Up Order for Expansion of RAUMEDIC’s Cleanroom Facilities

(IN BRIEF) Lindner Clean Rooms, a specialist in cleanroom solutions, has secured a follow-up order from RAUMEDIC AG, a global developer and manufacturer for the medical technology and pharmaceutical industries. RAUMEDIC is expanding its cleanroom facilities in its Helmbrechts headquarters … Read the full press release

AstraZeneca Showcases Promising Advances in Lung Cancer Treatments at IASLC Conference 2023

(IN BRIEF) AstraZeneca is advancing its lung cancer portfolio at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer. The company is aiming to have an AstraZeneca medicine for over half of all … Read the full press release

ESC Congress 2023 Unveils Cutting-Edge Cardiovascular Research: Hot Line Studies and Guideline Updates to Shape Medical Practice

(IN BRIEF) The ESC Congress 2023 is set to take place from August 25 to 28 in Amsterdam, offering the latest in cardiovascular science. The event will feature a packed Press Conference program, presenting results from 30 major studies in … Read the full press release

Switzerland’s First Proton Radiotherapy for Oesophageal Cancer Conducted in Landmark Clinical Trial

(IN BRIEF) The Paul Scherrer Institute (PSI) has administered proton radiotherapy to a 67-year-old patient with oesophageal cancer, marking the first time this treatment has been used in Switzerland for such a case. The treatment is part of a collaborative … Read the full press release

Research Reveals Immunocompromised Individuals with Limited COVID-19 Antibodies at Higher Risk: MELODY Study

(IN BRIEF) A recent study, conducted by a collaborative team including the University of Southampton and Imperial College London, has identified that individuals with compromised immune systems, such as those with solid organ transplants, rare autoimmune diseases, or blood cancer … Read the full press release